Cj. Schultz et al., RISK-FACTORS WHICH PREDICT PERSISTENT CANCER IN THE ABNORMAL LARYNX FOLLOWING DEFINITIVE IRRADIATION, European journal of cancer. Part B, Oral oncology, 31B(5), 1995, pp. 310-314
Laryngeal abnormalities following definitive irradiation for carcinoma
of the larynx are common. The objective of this study was to identify
risk factors for persistent cancer in such patients who were found to
have abnormal larynges following definitive irradiation. A retrospect
ive evaluation of 185 consecutive patients undergoing primary irradiat
ion for a glottic or supraglottic laryngeal squamous carcinoma treated
between 1976 and 1990 at the Affiliated Hospitals of the Medical Coll
ege of Wisconsin was performed. From chart review, data concerning sit
e, stage, intent of treatment, smoking history, treatment dose, fracti
on size, failure patterns, and outcome were obtained. In addition, wor
risome signs and symptoms including ulceration, dysphasia, odynophagia
, airway distress, aphonia, blood, pain, oedema, aspiration, and pneum
onia were recorded. Univariate association with failure and a persiste
ntly abnormal laryngeal examination was assessed using the Mantel-Haen
szel test. The odds ratio was used to estimate relative risk associate
d with dichotomous risk factors. Disease-free and overall survival wer
e estimated using Kaplan-Meier methodology. The log rank test was used
to compare survival as defined by the levels of various risk factors.
Two-year disease-free survival was 83% (T-1= 93%, T-2= 72%, T-3/T4=66
%). Primary failure was associated with the presence of an abnormal ex
amination (P=0.001), tracheotomy (P=0.001), symptom index (P=0.002), a
phonia (P=0.003), advanced T stage (P=0.03), and lower total dose (P=0
.03). Of 151 patients who survived 6 months disease-free with an intac
t larynx, an abnormal examination was seen in those with advanced T st
age (P=0.002), supraglottic primary (P=0.003), symptom index (P=0.008)
, eventual failure at the primary site (P=0.008), continued smoking (P
=0.01), and higher total dose (P=0.01). The symptom index (total signs
and symptoms of airway distress, aphonia, ulceration, pain, oedema, d
ysphagia, blood production, aspiration, pneumonia, and odynophagia) wa
s correlated with primary failure and continued smoking. Of 37 patient
s with continually normal examinations, only 1 (3%) failed at the prim
ary site. Of 102 who survived 6 months but with an abnormal examinatio
n, 22 (22%) eventually developed a primary failure. Persistently abnor
mal larynges are common after radiation therapy, yet not all harbour c
ancer. Risk factors for persistent cancer include stage, airway, total
dose, and symptom index. Patients whose larynges return to normal aft
er radiation rarely fail at the primary site.